📰 Cognitive Sciences News
Page 54 - Cognitive Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cognitive Sciences. Real-time updates on events, politics, business and more.
October 16, 2021
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the “eureka moment” 20 years ago when he realized that a severe developmental brain disorder
October 15, 2021
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the “eureka moment” 20 years ago when he realized that a severe developmental brain
October 13, 2021
Biomaterials Market Acquire Huge Growth, Global Opportunities and Trends to 2027
October 12, 2021
Biomaterials Market Acquire Huge Growth, Global Opportunities and Trends to 2027
October 8, 2021
BRYN MAWR, PA. (PRWEB) October 08, 2021 -- Dr. Jason D. Bloom is an award-winning, Ivy-League trained, double board-certified facial plastic & reconstructive
October 6, 2021
On Oct. 5, the National Institutes of Health announced the names of 106 scientists who have been awarded grants through the High-Risk, High-Reward
October 5, 2021
The Roundtable Panel: a daily open discussion of issues in the news and beyond. Today's panelists are WAMC’s Alan Chartock, Albany Chief City Auditor Dorcey Applyrs, investigative journalist and UAlbany Adjunct Professor Rosemary Armao, Tetherless World Professor of Computer, Web and Cognitive Sciences at RPI and Director of the RPI-IBM Artificial Intelligence research collaboration Jim Hendler, and former Associate Editor of The Times Union, Mike Spain.
October 3, 2021
Students Claire Janezic and Kayla Gunderson have performed at all three concerts so far this semester, and I had the amazing opportunity to ask them what it’s like to play inside the bell tower of Rush Rhees.
September 30, 2021
NSFs mission is to advance the progress of science, a mission accomplished by funding proposals for research and education made by scientists, engineers, and educators from across the country.
September 30, 2021
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.